$ZURA
Zura Bio Ltd
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · La Jolla, CA
ZURA chart
What traders are saying about $ZURA
Latest postsZura Bio Ltd news
- Oppenheimer maintains Zura Bio at Outperform, lowers price target to $5 from $16
TradingView ·
- Top 5 More Healthcare Gainers Among the Market Movers on November 10, 2026: Senseonics (NASDAQ:SENS) +26.12%, Zura Bio (NASDAQ:ZURA) +19.31%, Harrow, Inc. (NASDAQ:HROW) +15.85%, Zentalis (NASDAQ:ZNTL) +12.36%, IRulya Therapeutic
kalkine.ca ·
- ZURA SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Zura Bio Limited
Morningstar ·
- Oppenheimer Adjusts Price Target on Zura Bio to $5 From $16, Maintains Outperform Rating
marketscreener.com ·
- ZURA Investors Have Opportunity to Join Zura Bio Limited Fraud Investigation with SBS Law
Business Wire ·
- Zura Bio shares sink after tibulizumab misses Phase II HS trial
The Pharma Letter ·
- Zura Bio discontinues tibulizumab in HS after Phase II trial failure
clinicaltrialsarena.com ·
- Guggenheim cuts Zura Bio stock price target to $8 on trial failure By Investing.com
Investing.com India ·
- Zura Bio shares plunge 72% after Phase 2 trial of lead drug tibulizumab fails primary endpoint.
Pluang ·
- Zura Bio Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Zura Bio Limited (ZURA)
PR Newswire ·
- Zura Bio Limited Stock 12‑Month Price Target Cut to $13.5, Implies 230% Upside
TradingView ·
- Zura Bio Shares Plunge 76% After Phase 2 Trial Failure
grafa.com ·
Zura Bio Ltd key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$68.7M | -$52.4M | -$60.4M | -$25.7M |
| Diluted EPS | $-1.06 | $-0.60 | $-2.09 | $-141.97 |
| Total assets (year end) | $113.9M | $179.5M | $100.8M | $5.3M |
| Cash and equivalents (year end) | $109.4M | $176.5M | $99.8M | $13,785 |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Zura Bio Ltd
- Ticker
- ZURA (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- La Jolla, CA
- Incorporated in
- Cayman Islands
- Fiscal year end
- December 31
- SEC CIK
- 1855644
- Former names
- JATT Acquisition Corp
Frequently asked questions
What exchange is Zura Bio Ltd listed on?
Zura Bio Ltd trades on the Nasdaq under the ticker symbol ZURA.
What industry is Zura Bio Ltd in?
Zura Bio Ltd is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Zura Bio Ltd headquartered?
Zura Bio Ltd's business address on file with the SEC is in La Jolla, CA.
When does Zura Bio Ltd's fiscal year end?
Zura Bio Ltd's fiscal year ends on December 31.